The findings disprove claims that price increases do not reduce patient access to and use of certain medications, said researchers at the Cleveland Clinic.
After steep price hikes, use of two common heart medications declined significantly in U.S. hospitals, a new study shows.
The drugs, nitroprusside, or Nitropress, and isoproterenol, or Isuprel, have been used for decades.
The findings disprove claims that price increases do not reduce patient access to and use of certain medications, the Cleveland Clinic researchers said.
“In public testimony, it had been stated that these price increases would not decrease patient access or utilization of these two critical drugs, both of which have been used for decades in patient care,” said lead author Dr. Umesh Khot, vice chairman of cardiovascular medicine.
“However, our research shows that these price hikes are not benign. Further research will determine if there has been any effect on patient outcomes,